Genetic Technologies has announced the launch of its Covid-19 Serious Disease Risk Test in the US through a collaboration with the biotechnology company Infinity BiologiX. As per the agreement, IBX will manufacture, sell, and distribute GENE’s test across its recognised network. The Covid-19 risk test is available to all individuals aged 18 years and older.

A Montana State University (MSU) team has illustrated how ancient strategies used by bacteria to battle viruses can be repurposed to fight Covid-19. Using CRISPR, a bacterial immune system technology, MSU researchers have developed a new diagnostic tool to accurately detect even small amounts of the SARS-CoV-2 virus in patient samples in under 30 minutes. Researchers claim that the test can also be used to identify other viruses such as Ebola and Zika.

The University of Bath has been working on a world-first handheld Covid-19 test device, which is expected to deliver accurate results in just 10 minutes. Developed by Bath’s Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) members, the LoCKamp test conducts a genetic-based diagnosis, offering high accuracy levels in detecting the SARS-Cov-2 virus. It is about the size of a mobile phone and is able to take samples, identify DNA sequences and reveal results in within ten minutes.